Bioequivalence Study for Fluticasone Propionate 500 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers

Condition:   Bioequivalence Interventions:   Drug: Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals;   Drug: ADVAIR DISKUS® 500/50 Sponsors:   Respirent Pharmaceuticals Co Ltd.;   Becro Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials